In the modern era of medicine, the bridge between organic compounds and pharmaceutical efficacy is narrowing. We provide high-purity APIs and food ingredients that meet stringent global pharmacopeia standards (USP, EP, JP). Our solutions address the rising demand for preventative healthcare and chronic disease management through bio-available organic molecules.
Leveraging China's vast agricultural heritage with modern processing technology, we offer a "Soil-to-Shelf" traceability model. By optimizing the extraction of botanical compounds like Astragalus and Milk Thistle, we assist global brands in maintaining clean-label integrity while ensuring maximum therapeutic potency.
As a leading exporter, we tackle the volatility of the global raw material market. With three strategic production bases in Shandong, Zhejiang, and Hebei, QLU Health ensures a diversified supply chain that mitigates geopolitical and climate-related risks for our international partners.
The global organic food and pharmaceutical ingredient market is projected to reach $450 billion by 2030. China has evolved from a simple volume exporter to a high-value technical innovator. Xian QLU Health Pharmaceutical Technology Co., Ltd. stands at the forefront of this transformation, integrating R&D with large-scale industrial manufacturing.
Currently, the market demands "Information Gain"—transparency in how ingredients are sourced and the scientific validation behind their efficacy. Our move towards organic-certified intermediates reflects the global consumer shift toward "Conscious Consumption" and holistic wellness.
Transitioning from traditional solvent extraction to Supercritical CO2 and Ultrasound-Assisted Extraction (UAE) to preserve delicate phytochemical structures.
Implementation of machine learning algorithms for real-time purity monitoring and predictive batch stability analysis across our production lines.
Our goal is to achieve 100% waste-to-energy conversion in our Hebei facility, aligning with global ESG standards for pharmaceutical manufacturing.
Xian QLU Health Pharmaceutical Technology Co., Ltd. is a premier entity engaged in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, intermediates, and chemicals. Headquartered in the historic city of Xian, China, we operate with a global mindset and local precision.
Our infrastructure includes 3 sophisticated production bases in Shandong, Zhejiang, and Hebei. Each facility is backed by decades of industrial experience and holds certifications including GMP, ISO, FAMI-QS, KOSHER, and HALAL.
Focus on pharma, food ingredients, and vitamins.
Expanded into global marketing of APIs and chemical intermediates.
Integrated production-marketing model for APIs.
Devoted to full-spectrum development of advanced chemicals.
In the ever-changing pharmaceutical industry, the spirit of QLU is characterized by flexibility and adaptability. We embrace emerging technologies, actively adopt new scientific advancements, and continuously evolve to meet the evolving needs of patients and healthcare providers.
We have established Strategic Marketing Partners in Mumbai (India) and Dubai (UAE). This allows us to provide real-time support, localized logistics, and navigate the complex regulatory frameworks of the Middle East and South Asia.
Our inspection facilities utilize HPLC, GC, and MS technologies to ensure every batch meets the "Certificate of Analysis" (COA) requirements. We provide full documentation support for DMF (Drug Master Files) and CEP filings.
Fortifying health supplements with high-purity Vitamin B3, Magnesium, and Milk Thistle extracts for metabolic and liver support.
Providing essential pain relief and calcium supplements (Cuttlefish bone) for pets and livestock, ensuring animal welfare.
Supplying high-grade stainless steel coils and specialized intermediates for medical equipment and laboratory infrastructure.
Developing anti-fatigue and hypertension management products specifically designed for the aging population demographic.
QLU Health
